Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (ALLSTAR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Capricor Inc.
Sponsor:
Collaborators:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
California Institute for Regenerative Medicine (CIRM)
Information provided by (Responsible Party):
Capricor Inc.
ClinicalTrials.gov Identifier:
NCT01458405
First received: October 20, 2011
Last updated: September 13, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2021
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)